CAPR
NASDAQ · Biotechnology
Capricor Therapeutics Inc
$9.06
-0.36 (-3.82%)
Open$9.30
Previous Close$9.42
Day High$9.36
Day Low$8.96
52W High$40.37
52W Low$2.96
Volume—
Avg Volume2.85M
Market Cap499.41M
P/E Ratio—
EPS$-2.45
SectorBiotechnology
Analyst Ratings
Hold
16 analysts
Price Target
+589.2% upside
Current
$9.06
$9.06
Target
$62.44
$62.44
$34.96
$62.44 avg
$82.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 30.52M | 187.20M | 168.99M |
| Net Income | -55,455,340 | 36.18M | 32.84M |
| Profit Margin | -181.7% | 19.3% | 19.4% |
| EBITDA | -56,521,974 | 59.64M | 51.36M |
| Free Cash Flow | — | 19.67M | 27.43M |
| Rev Growth | +352.7% | +21.4% | +1.7% |
| Debt/Equity | 0.02 | 1.29 | 1.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |